Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-comparator-controlled, parallel-group, phase 2 trial
Pathogenic mutations in UPS components as direct drivers of neurodegeneration The indispensable role of the UPS in neuronal health is most clearly illustrated by familial forms of NDDs caused directly by mutations in UPS constituents
And from there, the plan is to continue to expand our product range to a few more foundational products that were still in the process of formulating and launching this year and next year and then some more specialized products for particular health conditions and goals as we go
Propafenone shows class Ic and class II antiarrhythmic effects
Modification in lifestyle & metformin is recommended as first-line therapy to treat type-2 diabetes mellitus [7]